Open AccessJournal Article
Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.
H J Jennings,C Lugowski +1 more
Reads0
Chats0
TLDR
Hyperimmunization of mice with the groups A and C polysaccharide-tetanus toxoid conjugate produced antisera with good bactericidal activity against their respective homologous organisms, and indicated the potential of these conjugates as potential human vaccines.Abstract:
The successful coupling of the meningococcal groups A, B, and C polysaccharides to tetanus toxoid to yield water soluble conjugates is described. Reactive aldehyde groups were strategically introduced into the terminal residues of the polysaccharides by the controlled periodate oxidation of the native groups B and C polysaccharides and of the group A polysaccharide previously modified by the reduction of its terminal reducing N-acetyl-mannosamine residue. This produced essentially monovalent polysaccharide molecules, which were subsequently covalently linked to tetanus toxoid by means of reductive amination. Although the groups A and C polysaccharides proved to be poor immunogens in rabbits and mice, their tetanus toxoid conjugates produced high levels of polysaccharide-specific antibodies in both animals. By contrast, even in the form of its tetanus toxoid conjugate, the group B polysaccharide failed to elicit homologous polysaccharide-specific antibodies in either animal; a major proportion of the antibodies actually produced had a specificity for the linkage area of the conjugate. This evidence is compatible with the hypothesis of the poor immunogenicity of the group B polysaccharide being structure related. Hyperimmunization of mice with the groups A and C polysaccharide-tetanus toxoid conjugates produced antisera with good bactericidal activity against their respective homologous organisms, and indicated the potential of these conjugates as potential human vaccines.read more
Citations
More filters
Journal ArticleDOI
ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS: Implications for Vaccine Development and Pathogenesis
TL;DR: Glycopeptides containing polysialic acid units were isolated from human and rat brain and tested for reactivity with antibodies against meningococcal capsules.
Journal ArticleDOI
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.
JohnB Robbins,Robert Austrian,Lee Cj,Suresh C. Rastogi,Gerald Schiffman,J. Henrichsen,P. H. Mäkelä,Claire V. Broome,Richard R. Facklam,Tiesjema Rh +9 more
Journal ArticleDOI
NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci.
TL;DR: Comparison of the humoral immune responses of normal BALB/c mice and autoimmune NZB mice to hyperimmunization showed that, although both strains mounted a weak meningococcal B polysaccharide-specific IgM response, only the NZB strain mounted an IgG response.
Journal ArticleDOI
Immunology of bacterial polysaccharide antigens.
TL;DR: The T-lymphocyte independent nature of a polysaccharide may be overcome by conjugating the native or depolymerised poly Saccharide to a protein carrier, and neoglycoconjugates have been proven to be efficient in inducing T-LYmphocyte dependent immunity and to protect both infants as well as elderly from disease.
Journal ArticleDOI
Further Studies on the Immunogenicity of Haemophilus influenzae Type b and Pneumococcal Type 6A Polysaccharide-Protein Conjugates
TL;DR: This method of synthesis provided conjugates capable of inducing protective levels of antibodies to both the polysaccharides and carrier proteins and suggesting that additional carrier protein (TT) enhanced the anti-polysaccharide response.